ConciergeMD uses a medical evaluation to determine whether or not the peptide therapy is appropriate
Yang M, Wu E, Tang W, Qian J, Zhan C
Cross-talk between alpha7 nAchR and NMDAR revealed by protein profiling
For context on how this compares to other peptide administration schedules, the fat loss peptide overview covers dosing frequency across multiple compounds
Daily use is common in research protocols, typically for 4-8 week cycles
Then 5 days later, both eyes were injected with vehicle or Eru (n = 7 for AAV2-Scr+vehicle, n = 8 for AAV2-Scr+Eru, n = 7 for AAV2-shTMEM19+vehicle, n = 8 for AAv2-shTMEM19+Eru), Two-sided multiple unpaired t-test with Benjamini-Krieger-Yekutieli FDR correction